Rapid resolution of erythrodermic atopic dermatitis with upadacitinib: A case report

被引：0
|
作者：
Saad, Mysa [1 ]
Guirguis, Marina [1 ]
Hamm, Camille [2 ]
Bose, Reetesh [1 ,2 ]
机构：
[1] Univ Ottawa, Fac Med, Roger Guindon Hall, Ottawa, ON, Canada
[2] Ottawa Hosp, Div Dermatol, 737 Parkdale Ave, Ottawa, ON K1Y 4M9, Canada
来源：
SAGE OPEN MEDICAL CASE REPORTS | 2024年 / 12卷
关键词：
Erythrodermic atopic dermatitis; upadacitinib; JAK inhibitor; dupilumab; prednisone; DUPILUMAB; SAFETY;
D O I：
10.1177/2050313X241260497
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Atopic dermatitis is a chronic inflammatory skin disease that may progress to erythroderma in severe cases. Biologic agents such as dupilumab have recently become the mainstay of systemic treatment for moderate-to-severe cases, yet many patients remain refractory to therapy. Here, we present a case of erythrodermic atopic dermatitis, resistant to prednisone and dupilumab, with remarkably rapid achievement of remission following treatment with upadacitinib, an oral selective Janus kinase 1 inhibitor.
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Erythrodermic atopic dermatitis resistant to dupilumab and baricitinib successfully treated with upadacitinib
    Valente, Clara
    Duarte, Bruno
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (04) : E493 - E495
  • [2] Atopic dermatitis treated with tralokinumab and upadacitinib combination therapy: A case report
    Lansang, Rafael Paolo
    Zhao, Irene X.
    Lansang, Perla
    SAGE OPEN MEDICAL CASE REPORTS, 2023, 11
  • [3] Upadacitinib improved alopecia areata in a patient with atopic dermatitis: A case report
    Cantelli, Mariateresa
    Martora, Fabrizio
    Patruno, Cataldo
    Nappa, Paola
    Fabbrocini, Gabriella
    Napolitano, Maddalena
    DERMATOLOGIC THERAPY, 2022, 35 (04)
  • [4] Concurrent vitiligo and atopic dermatitis successfully treated with upadacitinib: a case report
    Pan, Ting
    Mu, Yuzhu
    Shi, Xin
    Chen, Lingling
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2023, 34 (01)
  • [5] ATOPIC DERMATITIS REFRACTORY TO DUPILUMAB SUCCESSFULLY CONTROLLED BY UPADACITINIB - A CASE REPORT
    Hong, Narang
    Park, So Yoon
    Kook, Hyung Don
    Lee, Dong Heon
    Jung, Hye Jung
    Park, Mi Youn
    Ahn, Jiyoung
    ACTA DERMATO-VENEREOLOGICA, 2022, 102 : 29 - 30
  • [6] Successful treatment of atopic dermatitis by switching from upadacitinib to abrocitinib: a case report
    Tsai, Ya-Chu
    Tsai, Tsen-Fang
    EUROPEAN JOURNAL OF DERMATOLOGY, 2023, 33 (06) : 699 - 701
  • [7] Melano-erythrodermic folliculotropic mycosis fungoides misdiagnosed as a case of recalcitrant atopic dermatitis: A case report
    Alghamdi, Nada
    Alzammami, Haya
    Alfaraj, Maryam Mohammed
    SAGE OPEN MEDICAL CASE REPORTS, 2025, 13
  • [8] Upadacitinib for Patients with Atopic Dermatitis
    不详
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2022, 147 (09) : 506 - 506
  • [9] Upadacitinib for the treatment of alopecia areata and severe atopic dermatitis in a paediatric patient: A case report
    Bourkas, Adrienn N.
    Sibbald, Cathryn
    SAGE OPEN MEDICAL CASE REPORTS, 2022, 10
  • [10] Upadacitinib in concurrent Crohn's disease, atopic dermatitis and alopecia areata: A case report
    Novielli, D.
    Foti, C.
    Principi, M.
    Mortato, E.
    Romita, P.
    Dell'Aquila, P.
    Di Leo, A.
    Ambrogio, F.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024, 38 (01) : E8 - E10
12345